Randomized controlled trials of Vitamin D and cancer incidence: A modeling study

PLoS ONE

Volumn 12, Issue 5, 2017, Pages

  Grant, William B ^a   Boucher, Barbara J ^b  

^a Sunlight   (United States)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; VITAMIN D; 25-HYDROXYVITAMIN D; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER INCIDENCE; CANCER RISK; CLINICAL TRIAL (TOPIC); DRUG EFFECT; DRUG EFFICACY; HUMAN; NEBRASKA; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEASONAL VARIATION; SUMMER; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION; WINTER; AGED; ANALOGS AND DERIVATIVES; BLOOD; INCIDENCE; MIDDLE AGED; NEOPLASM; ODDS RATIO; PROCEDURES; PROPORTIONAL HAZARDS MODEL; SEASON; THEORETICAL MODEL;

AGED; ANTINEOPLASTIC AGENTS; HUMANS; INCIDENCE; MIDDLE AGED; MODELS, THEORETICAL; NEBRASKA; NEOPLASMS; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEASONS; VITAMIN D;

EID: 85018983161     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0176448     Document Type: Article

References (46)

1. Moukayed M, Grant WB. Molecular link between vitamin D and cancer prevention. Nutrients. 2013; 5 (10): 3993-4021. Epub 2013/10/03. PubMed Central PMCID: PMC3820056. https://doi.org/10.3390/nu5103993 PMID: 24084056
2. Grant WB Roles of Solar UVB and Vitamin D in Reducing Cancer Risk and Increasing Survival. Anticancer research. 2016; 36(3): 1357-70. Epub 2016/03/16. PMID: 26977037
3. Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? International journal of epidemiology. 1980; 9(3): 227-31. Epub 1980/09/01. PMID: 7440046
4. Grant WB 25-Hydroxyvitamin D and Breast Cancer, Colorectal Cancer, and Colorectal Adenomas: Case-Control versus Nested Case-Control Studies. Anticancer research. 2015; 35(2): 1153-60. Epub 2015/02/11. PMID: 25667506
5. Muller DC, Scelo G, Zaridze D, Janout V, Holcatova I, Navratilova M, et al. Circulating 25-hydroxyvitamin D3 and survival after diagnosis with kidney cancer. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2015; 24(8): 1277-81. PubMed Central PMCID: PMC4526455.
6. Afzal S, Bojesen SE, Nordestgaard BG. Low plasma 25-hydroxyvitamin D and risk of tobacco-related cancer. Clinical chemistry. 2013; 59(5): 771-80. Epub 2013/03/19. https://doi.org/10.1373/clinchem.2012.201939 PMID: 23503722
7. Wolpin BM, Ng K, Bao Y, Kraft P, Stampfer MJ, Michaud DS, et al. Plasma 25-hydroxyvitamin D and risk of pancreatic cancer. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2012; 21(1): 82-91. PubMed Central PMCID: PMC3253914.
8. Fanidi A, Muller DC, Midttun O, Ueland PM, Vollset SE, Relton C, et al. Circulating vitamin D in relation to cancer incidence and survival of the head and neck and oesophagus in the EPIC cohort. Sci Rep. 2016; 6: 36017. Epub 2016/11/05. PubMed Central PMCID: PMC5095706. https://doi.org/10.1038/srep36017 PMID: 27812016
9. McDonnell SL, Baggerly C, French CB, Baggerly LL, Garland CF, Gorham ED, et al. Serum 25-Hydroxyvitamin D Concentrations >/ = 40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study. PloS one. 2016; 11(4): e0152441. Epub 2016/04/07. PubMed Central PMCID: PMC4822815. https://doi.org/10.1371/journal.pone.0152441 PMID: 27049526
10. Moukayed M, Grant WB. The roles of UVB and vitamin D in reducing risk of cancer incidence and mortality: A review of the epidemiology, clinical trials, and mechanisms. Rev Endocr Metab Disord. 2017. Epub 2017/02/19.
11. Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. The lancet Diabetes & endocrinology. 2014; 2(1): 76-89. Epub 2014/03/14.
12. Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ. 2014; 348: g2035. Epub 2014/04/03. PubMed Central PMCID: PMC3972415. https://doi.org/10.1136/bmj.g2035 PMID: 24690624
13. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. The American journal of clinical nutrition. 2007; 85(6): 1586-91. Epub 2007/06/09. PMID: 17556697
14. Lappe J, Watson P, Travers-Gustafson D, Recker R, Garland C, Gorham E, et al. Effect of Vitamin D and Calcium Supplementation on Cancer Incidence in Older Women: A Randomized Clinical Trial. JAMA: the journal of the American Medical Association. 2017; 317(12): 1234-43. Epub 2017/03/30. https://doi.org/10.1001/jama.2017.2115 PMID: 28350929
15. Bolland MJ, Grey A, Gamble GD, Reid IR. Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set. The American journal of clinical nutrition. 2011; 94(4): 1144-9. Epub 2011/09/02. PubMed Central PMCID: PMC3173029. https://doi.org/10.3945/ajcn.111.015032 PMID: 21880848
16. Heaney RP Guidelines for optimizing design and analysis of clinical studies of nutrient effects. Nutrition reviews. 2014; 72(1): 48-54. Epub 2013/12/18. https://doi.org/10.1111/nure.12090 PMID: 24330136
17. Grant WB, Garland CF. The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer research. 2006; 26(4A): 2687-99. Epub 2006/08/05. PMID: 16886679
18. Canada S. Consumer Price Index, historical summary http://www.statcan.gc.ca/tables-tableaux/sumsom/l01/cst01/econ150a-eng.htm2016 [cited 2016 September 20, 2016].
19. Grant WB, Whiting SJ, Schwalfenberg GK, Genuis SJ, Kimball SM. Estimated economic benefit of increasing 25-hydroxyvitamin D concentrations of Canadians to or above 100 nmol/L. Dermato-endocrinology. 2016; 8(1): e1248324. Epub 2016/12/13. PubMed Central PMCID: PMC5129897. https://doi.org/10.1080/19381980.2016.1248324 PMID: 27942348
20. Kroll MH, Bi C, Garber CC, Kaufman HW, Liu D, Caston-Balderrama A, et al. Temporal relationship between vitamin D status and parathyroid hormone in the United States. PloS one. 2015; 10(3): e0118108. PubMed Central PMCID: PMC4349787. https://doi.org/10.1371/journal.pone.0118108 PMID: 25738588
21. Garland CF, French CB, Baggerly LL, Heaney RP. Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention. Anticancer research. 2011; 31(2): 607-11. Epub 2011/03/08. PMID: 21378345
22. Engelman CD, Meyers KJ, Iyengar SK, Liu Z, Karki CK, Igo RP Jr, et al. Vitamin D intake and season modify the effects of the GC and CYP2R1 genes on 25-hydroxyvitamin D concentrations. The Journal of nutrition. 2013; 143(1): 17-26. Epub 2012/11/30. PubMed Central PMCID: PMC3521459. https://doi.org/10.3945/jn.112.169482 PMID: 23190755
23. Thakkar JP, McCarthy BJ, Villano JL. Age-specific cancer incidence rates increase through the oldest age groups. The American journal of the medical sciences. 2014; 348(1): 65-70. Epub 2014/05/09. PubMed Central PMCID: PMC4119927. https://doi.org/10.1097/MAJ.0000000000000281 PMID: 24805784
24. McCullough ML, Bandera EV, Moore DF, Kushi LH. Vitamin D and calcium intake in relation to risk of endometrial cancer: a systematic review of the literature. Preventive medicine. 2008; 46(4): 298-302. Epub 2007/12/25. PubMed Central PMCID: PMC2442474. https://doi.org/10.1016/j.ypmed.2007.11.010 PMID: 18155758
25. Fedirko V, Torres-Mejia G, Ortega-Olvera C, Biessy C, Angeles-Llerenas A, Lazcano-Ponce E, et al. Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women. Cancer causes & control: CCC. 2012; 23(7): 1149-62. Epub 2012/05/25.
26. Qin B, Moorman PG, Alberg AJ, Barnholtz-Sloan JS, Bondy M, Cote ML, et al. Dairy, calcium, vitamin D and ovarian cancer risk in African-American women. British journal of cancer. 2016; 115(9): 1122-30. Epub 2016/10/26. PubMed Central PMCID: PMC5117784. https://doi.org/10.1038/bjc.2016.289 PMID: 27632371
27. Bikle DD Vitamin D and cancer: the promise not yet fulfilled. Endocrine. 2014; 46(1): 29-38. PubMed Central PMCID: PMC3976762. https://doi.org/10.1007/s12020-013-0146-1 PMID: 24402695
28. Bolland MJ, Grey A, Gamble GD, Reid IR. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: atrial sequential meta-analysis. The lancet Diabetes & endocrinology. 2014; 2 (4): 307-20. Epub 2014/04/08.
29. McNally JD, Iliriani K, Pojsupap S, Sampson M, O'Hearn K, McIntyre L, et al. Rapid normalization of vitamin D levels: a meta-analysis. Pediatrics. 2015; 135(1): e152-66. https://doi.org/10.1542/peds.2014-1703 PMID: 25511115
30. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. The American journal of clinical nutrition. 2003; 77(1): 204-10. Epub 2002/12/25. PMID: 12499343
31. Carlberg C, Haq A. The concept of the personal vitamin D response index. The Journal of steroid biochemistry and molecular biology. 2016. Epub 2016/12/31.
32. Zhang M, Zhao LJ, Zhou Y, Badr R, Watson P, Ye A, et al. SNP rs11185644 of RXRA gene is identified for dose-response variability to vitamin D3 supplementation: a randomized clinical trial. Sci Rep. 2017; 7: 40593. Epub 2017/01/13. PubMed Central PMCID: PMC5228186. https://doi.org/10.1038/srep40593 PMID: 28079136
33. Zittermann A, Ernst JB, Gummert JF, Borgermann J. Vitamin D supplementation, body weight and human serum 25-hydroxyvitamin D response: a systematic review. European journal of nutrition. 2014; 53(2): 367-74. Epub 2013/12/03. https://doi.org/10.1007/s00394-013-0634-3 PMID: 24292820
34. Kelly JL, Drake MT, Fredericksen ZS, Asmann YW, Liebow M, Shanafelt TD, et al. Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma. Cancer causes & control: CCC. 2012; 23(7): 1017-29. PubMed Central PMCID: PMC3589750.
35. Grant WB Effect of follow-up time on the relation between prediagnostic serum 25-hydroxyvitamin D and all-cause mortality rate. Dermato-endocrinology. 2012; 4(2): 198-202. PubMed Central PMCID: PMC3427200. https://doi.org/10.4161/derm.20514 PMID: 22928077
36. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA: the journal of the American Medical Association. 2002; 288(3): 321-33. Epub 2002/07/19. PMID: 12117397
37. Spedding S, Vanlint S, Morris H, Scragg R. Does vitamin D sufficiency equate to a single serum 25-hydroxyvitamin D level or are different levels required for non-skeletal diseases? Nutrients. 2013; 5 (12): 5127-39. Epub 2013/12/20. PubMed Central PMCID: PMC3875927. https://doi.org/10.3390/nu5125127 PMID: 24352091
38. Grant WB Vitamin D status: ready for guiding prostate cancer diagnosis and treatment? Clinical cancer research: an official journal of the American Association for Cancer Research. 2014; 20(9): 2241-3. Epub 2014/05/03.
39. Berry DJ, Dutton J, Fraser WD, Jarvelin MR, Hypponen E. Harmonization Study Between LC-MS/MS and Diasorin RIA for Measurement of 25-Hydroxyvitamin D Concentrations in a Large Population Survey. Journal of clinical laboratory analysis. 2016. Epub 2016/09/07.
40. Nikooyeh B, Samiee SM, Farzami MR, Alavimajd H, Zahedirad M, Kalayi A, et al. Harmonization of serum 25-hydroxycalciferol assay results from high-performance liquid chromatography, enzyme immunoassay, radioimmunoassay, and immunochemiluminescence systems: A multicenter study. Journal of clinical laboratory analysis. 2017. Epub 2017/02/09.
41. Kulcsar-Jakab E, Kalina E, Petho Z, Pap Z, Balogh A, Grant WB, et al. Standardizing 25-hydroxyvitamin D data from the HunMen cohort. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2017.
42. Marshall JE, Byrne SN. Does sunlight protect us from cancer? Photochemical & photobiological sciences: Official journal of the European Photochemistry Association and the European Society for Photobiology. 2017. Epub 2017/01/20.
43. von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. The British journal of nutrition. 2010; 103(4): 549-55. Epub 2009/09/29. https://doi.org/10.1017/S0007114509992017 PMID: 19781131
44. Wagner CL, Baggerly C, McDonnell S, Baggerly KA, French CB, Baggerly L, et al. Post-hoc analysis of vitamin D status and reduced risk of preterm birth in two vitamin D pregnancy cohorts compared with South Carolina March of Dimes 2009-2011 rates. The Journal of steroid biochemistry and molecular biology. 2016; 155(Pt B): 245-51. Epub 2015/11/12. https://doi.org/10.1016/j.jsbmb.2015.10.022 PMID: 26554936
45. Wagner CL, McNeil R, Hamilton SA, Winkler J, Rodriguez Cook C, Warner G, et al. A randomized trial of vitamin D supplementation in 2 community health center networks in South Carolina. American journal of obstetrics and gynecology. 2013; 208(2): 137 e1-13. Epub 2012/11/08. PubMed Central PMCID: PMC4365423.
46. Mirzakhani H, Litonjua AA, McElrath TF, O'Connor G, Lee-Parritz A, Iverson R, et al. Early pregnancy vitamin D status and risk of preeclampsia. The Journal of clinical investigation. 2016; 126(12): 4702-15. Epub 2016/11/15. PubMed Central PMCID: PMC5127689. https://doi.org/10.1172/JCI89031 PMID: 27841759